HEPARIN SODIUM

HEPARIN SODIUM was reported 14141 times

HEPARIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 12 0.9231
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 APPENDICOLITH 233 0.6021
3 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 31 0.4921
4 SLEEP DISORDER THERAPY 95 0.4798
5 ANTACID THERAPY 62 0.4769
6 HEPARIN RESISTANCE 49 0.4016
7 WHITE CLOT SYNDROME 13 0.3023
8 ANALGESIC THERAPY 96 0.2991
9 DRUG THERAPY 94 0.2773
10 HEPARIN-INDUCED THROMBOCYTOPENIA 1310 0.2656
11 CONGENITAL HIATUS HERNIA 50 0.2193
12 ANTICOAGULANT THERAPY 62 0.2183
13 MALIGNANT MELANOMA STAGE 0 41 0.1962
14 ANTI FACTOR X ACTIVITY INCREASED 10 0.1852
15 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 13 0.1548
16 HEPARIN-INDUCED THROMBOCYTOPENIA TEST 11 0.1358
17 BACTEROIDES INFECTION 30 0.1149
18 PROSTHETIC CARDIAC VALVE THROMBOSIS 12 0.1101
19 COAGULATION TIME SHORTENED 36 0.1081
20 VASCULAR ACCESS SITE HAEMORRHAGE 16 0.0994
21 PLATELET AGGREGATION INHIBITION 9 0.0978
22 HYPOALDOSTERONISM 21 0.0766
23 COAGULATION TIME ABNORMAL 22 0.0733
24 HYPERPHOSPHATAEMIA 127 0.0590
25 BLOOD PHOSPHORUS INCREASED 161 0.0589
26 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 12 0.0588
27 BULLOUS HAEMORRHAGIC DERMATOSIS 12 0.0571
28 GASTRODUODENAL ULCER 23 0.0546
29 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 44 0.0475
30 SUBCAPSULAR RENAL HAEMATOMA 10 0.0472
31 GRAFT THROMBOSIS 12 0.0458
32 ADRENAL HAEMORRHAGE 25 0.0447
33 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 216 0.0426
34 SPINAL EPIDURAL HAEMATOMA 25 0.0424
35 PERIRENAL HAEMATOMA 9 0.0415
36 OPERATIVE HAEMORRHAGE 17 0.0380
37 CONDUCTIVE DEAFNESS 12 0.0374
38 HAEMORRHAGIC INFARCTION 20 0.0364
39 RESTRICTIVE CARDIOMYOPATHY 11 0.0363
40 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 15 0.0358
41 INFECTIVE ANEURYSM 17 0.0343
42 VENOOCCLUSIVE DISEASE 85 0.0339
43 TOTAL LUNG CAPACITY DECREASED 52 0.0325
44 ENTEROCOCCUS TEST POSITIVE 21 0.0324
45 RED BLOOD CELLS URINE POSITIVE 30 0.0310
46 EXTRADURAL HAEMATOMA 41 0.0310
47 CEREBRAL VENOUS SINUS THROMBOSIS 26 0.0308
48 RETROPERITONEAL HAEMATOMA 67 0.0303
49 HAEMATOMA MUSCLE 35 0.0292
50 HEPATIC INFARCTION 11 0.0292
51 COAGULATION TIME PROLONGED 45 0.0291
52 VASCULAR STENT THROMBOSIS 58 0.0285
53 RENAL VEIN THROMBOSIS 19 0.0281
54 PRODUCT MEASURED POTENCY ISSUE 28 0.0278
55 INCISION SITE PAIN 31 0.0264
56 VOLUME BLOOD DECREASED 11 0.0261
57 APPENDICITIS 244 0.0261
58 FUNGAL SEPSIS 21 0.0253
59 RETROPERITONEAL HAEMORRHAGE 62 0.0251
60 AORTIC THROMBOSIS 29 0.0251
61 THROMBOSIS IN DEVICE 78 0.0238
62 VENTRICULAR FIBRILLATION 259 0.0233
63 IRON DEFICIENCY 104 0.0231
64 DRY GANGRENE 14 0.0220
65 BLOOD URIC ACID INCREASED 127 0.0220
66 ARTERIAL THROMBOSIS LIMB 9 0.0217
67 EPIDERMOLYSIS 10 0.0217
68 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
69 CARDIOGENIC SHOCK 306 0.0213
70 DEVICE RELATED THROMBOSIS 21 0.0213
71 SHOCK HAEMORRHAGIC 172 0.0211
72 HAEMOTHORAX 61 0.0210
73 LUNG OPACITY 54 0.0205
74 ABDOMINAL WALL HAEMATOMA 39 0.0200
75 HYPOPHOSPHATAEMIA 147 0.0199
76 CHRONIC SPONTANEOUS URTICARIA 23 0.0198
77 DELAYED GRAFT FUNCTION 14 0.0197
78 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 15 0.0196
79 COAGULATION TEST ABNORMAL 15 0.0195
80 MYASTHENIA GRAVIS 152 0.0188
81 HAND DERMATITIS 13 0.0188
82 HAEMOPERITONEUM 15 0.0187
83 PERIPHERAL ARTERY THROMBOSIS 26 0.0185
84 CARDIAC PROCEDURE COMPLICATION 11 0.0181
85 CEREBRAL HAEMATOMA 60 0.0178
86 CORONARY ARTERY THROMBOSIS 36 0.0178
87 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 15 0.0177
88 PERIPHERAL ISCHAEMIA 70 0.0171
89 CARDIAC VENTRICULAR THROMBOSIS 22 0.0170
90 PULMONARY ARTERY THROMBOSIS 13 0.0169
91 ARTERIAL THROMBOSIS 32 0.0165
92 CEREBELLAR HAEMORRHAGE 23 0.0161
93 VASCULAR PSEUDOANEURYSM 28 0.0161
94 HAEMORRHAGIC CEREBRAL INFARCTION 11 0.0157
95 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 24 0.0156
96 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 12 0.0156
97 PUNCTURE SITE HAEMORRHAGE 11 0.0155
98 PERICARDIAL HAEMORRHAGE 34 0.0155
99 INTRA-ABDOMINAL HAEMORRHAGE 37 0.0155
100 AORTIC STENOSIS 53 0.0152
101 PLEURITIC PAIN 42 0.0152
102 CATHETER SITE HAEMORRHAGE 37 0.0148
103 CEREBRAL PALSY 14 0.0147
104 JUGULAR VEIN THROMBOSIS 26 0.0146
105 THERAPEUTIC PRODUCT EFFECT INCREASED 17 0.0146
106 HEART TRANSPLANT 13 0.0144
107 INTESTINAL INFARCTION 13 0.0143
108 HYPERCOAGULATION 27 0.0142
109 ABDOMINAL COMPARTMENT SYNDROME 9 0.0141
110 ARTERIAL HAEMORRHAGE 16 0.0140
111 RENAL INFARCT 20 0.0138
112 SUPERIOR SAGITTAL SINUS THROMBOSIS 11 0.0138
113 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 17 0.0137
114 SPONTANEOUS HAEMATOMA 10 0.0134
115 EMBOLISM ARTERIAL 16 0.0133
116 MULTIPLE ORGAN DYSFUNCTION SYNDROME 377 0.0133
117 COMPARTMENT SYNDROME 34 0.0130
118 PHARYNGEAL HAEMORRHAGE 16 0.0130
119 VENA CAVA THROMBOSIS 21 0.0126
120 ELECTROMECHANICAL DISSOCIATION 10 0.0125
121 SERRATIA INFECTION 9 0.0121
122 RESPIRATORY SYMPTOM 34 0.0119
123 TROPONIN INCREASED 90 0.0118
124 URINARY TRACT INFECTION ENTEROCOCCAL 11 0.0118
125 INTRACARDIAC THROMBUS 36 0.0117
126 MUSCLE HAEMORRHAGE 47 0.0117
127 INTRAVENTRICULAR HAEMORRHAGE 29 0.0116
128 CARDIAC TAMPONADE 55 0.0116
129 SPLENIC INFARCTION 20 0.0115
130 DEVICE RELATED SEPSIS 23 0.0114
131 SUBCLAVIAN VEIN THROMBOSIS 13 0.0114
132 BLOOD FIBRINOGEN INCREASED 9 0.0114
133 INTRA-ABDOMINAL HAEMATOMA 14 0.0113
134 JOINT CONTRACTURE 12 0.0112
135 INCISION SITE HAEMORRHAGE 9 0.0111
136 BRAIN HERNIATION 33 0.0110
137 RENAL ARTERY STENOSIS 15 0.0109
138 SINUS ARREST 17 0.0108
139 PERITONEAL HAEMORRHAGE 15 0.0108
140 ATRIAL THROMBOSIS 22 0.0106
141 PROCEDURAL HYPOTENSION 9 0.0106
142 PRODUCT PACKAGING CONFUSION 25 0.0103
143 BENIGN PROSTATIC HYPERPLASIA 53 0.0103
144 COMPLICATIONS OF TRANSPLANTED KIDNEY 23 0.0101
145 CEREBRAL ARTERY EMBOLISM 12 0.0098
146 CATHETER RELATED COMPLICATION 11 0.0098
147 VENOUS THROMBOSIS 38 0.0097
148 DISSEMINATED INTRAVASCULAR COAGULATION 135 0.0096
149 ASCITES 281 0.0095
150 GANGRENE 57 0.0094
151 SKIN NECROSIS 49 0.0094
152 ENTEROCOCCAL BACTERAEMIA 10 0.0094
153 BLOOD LOSS ANAEMIA 21 0.0093
154 SPLENIC RUPTURE 15 0.0091
155 BLEEDING TIME PROLONGED 11 0.0091
156 APLASTIC ANAEMIA 47 0.0090
157 MIXED LIVER INJURY 27 0.0090
158 DEVICE INFUSION ISSUE 22 0.0089
159 TOXIC EPIDERMAL NECROLYSIS 133 0.0087
160 BLOOD CALCIUM INCREASED 76 0.0087
161 CLOSTRIDIUM TEST POSITIVE 19 0.0086
162 BREATH SOUNDS ABNORMAL 42 0.0085
163 HAEMORRHAGE INTRACRANIAL 127 0.0085
164 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
165 BRAIN DEATH 26 0.0084
166 HYPERLACTACIDAEMIA 22 0.0082
167 DRUG EFFECT LESS THAN EXPECTED 120 0.0081
168 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 138 0.0080
169 BACTERIAL INFECTION 149 0.0080
170 ANTIBODY TEST POSITIVE 13 0.0078
171 PERIPHERAL ARTERY OCCLUSION 11 0.0078
172 COAGULOPATHY 130 0.0078
173 HAEMODYNAMIC INSTABILITY 59 0.0077
174 POST PROCEDURAL HAEMATOMA 13 0.0077
175 HYPERLIPIDAEMIA 92 0.0077
176 HYPERPARATHYROIDISM SECONDARY 19 0.0076
177 UPPER GASTROINTESTINAL HAEMORRHAGE 124 0.0074
178 BREAST DISORDER 15 0.0073
179 MULTI-ORGAN FAILURE 127 0.0073
180 VENOUS THROMBOSIS LIMB 15 0.0073
181 PULSE ABSENT 34 0.0071
182 NEPHROGENIC ANAEMIA 33 0.0071
183 CELL DEATH 14 0.0071
184 PLATELET TRANSFUSION 9 0.0070
185 SUBARACHNOID HAEMORRHAGE 71 0.0070
186 BLOOD TEST ABNORMAL 97 0.0069
187 EXTREMITY NECROSIS 12 0.0069
188 BILIRUBIN CONJUGATED INCREASED 16 0.0068
189 LEG AMPUTATION 28 0.0068
190 HEPATIC CYTOLYSIS 86 0.0067
191 CYTOMEGALOVIRUS TEST POSITIVE 12 0.0067
192 SPINAL CORD COMPRESSION 26 0.0067
193 PULMONARY HAEMORRHAGE 52 0.0066
194 ISCHAEMIC HEPATITIS 9 0.0066
195 DIPLEGIA 13 0.0066
196 PROTEIN URINE PRESENT 32 0.0064
197 END STAGE RENAL DISEASE 117 0.0064
198 RENAL HAEMORRHAGE 13 0.0064
199 PLATELET DISORDER 16 0.0063
200 PULMONARY INFARCTION 15 0.0063
201 PELVIC VENOUS THROMBOSIS 9 0.0063
202 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
203 STOMACH DISCOMFORT 32 0.0062
204 CARDIOVASCULAR INSUFFICIENCY 10 0.0061
205 POST PROCEDURAL HAEMORRHAGE 71 0.0061
206 SPINAL CORD DISORDER 10 0.0061
207 NEUTROPHIL COUNT INCREASED 62 0.0060
208 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 20 0.0060
209 HAEMORRHAGIC TRANSFORMATION STROKE 9 0.0060
210 EMBOLIC STROKE 21 0.0060
211 HAEMORRHAGE SUBCUTANEOUS 21 0.0059
212 TRANSFUSION 62 0.0059
213 CEREBELLAR INFARCTION 10 0.0059
214 HAEMATOMA 153 0.0059
215 EOSINOPHILIA 103 0.0059
216 ASPIRATION 64 0.0058
217 HYPONATRAEMIA 329 0.0058
218 NEURALGIA 142 0.0058
219 CEREBRAL HAEMORRHAGE 208 0.0058
220 HYPOPROTEINAEMIA 11 0.0058
221 RASH MORBILLIFORM 16 0.0058
222 LYMPHOCYTE COUNT DECREASED 102 0.0058
223 CEREBRAL INFARCTION 140 0.0057
224 FUNGAEMIA 9 0.0057
225 THROMBOSIS 459 0.0057
226 ULCER 90 0.0057
227 HYPOVOLAEMIC SHOCK 27 0.0056
228 HYPERURICAEMIA 23 0.0056
229 DUODENAL ULCER HAEMORRHAGE 16 0.0056
230 ANAPHYLACTOID REACTION 23 0.0056
231 PULMONARY EMBOLISM 524 0.0055
232 CEREBRAL VENOUS THROMBOSIS 10 0.0055
233 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
234 INTESTINAL ISCHAEMIA 30 0.0054
235 RESUSCITATION 9 0.0054
236 LOW BIRTH WEIGHT BABY 43 0.0054
237 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 42 0.0054
238 ELECTRIC SHOCK SENSATION 15 0.0054
239 BLOOD CULTURE POSITIVE 16 0.0053
240 PRODUCT CONTAMINATION 19 0.0053
241 SUBDURAL HAEMATOMA 76 0.0053
242 BACTERAEMIA 63 0.0053
243 VASCULAR OCCLUSION 11 0.0052
244 PARAPLEGIA 15 0.0052
245 CYTOMEGALOVIRUS VIRAEMIA 23 0.0052
246 INCORRECT DRUG ADMINISTRATION RATE 22 0.0052
247 HYPOALBUMINAEMIA 40 0.0051
248 PROCEDURAL HAEMORRHAGE 20 0.0051
249 POOR QUALITY DRUG ADMINISTERED 33 0.0051
250 PROCEDURAL COMPLICATION 39 0.0051
251 VENOOCCLUSIVE LIVER DISEASE 25 0.0051
252 DEEP VEIN THROMBOSIS 323 0.0050
253 PSEUDOMEMBRANOUS COLITIS 11 0.0049
254 PROTHROMBIN TIME PROLONGED 29 0.0048
255 GOUT 87 0.0048
256 THERAPEUTIC PRODUCT EFFECT DECREASED 217 0.0048
257 BLOOD UREA INCREASED 81 0.0048
258 OLIGURIA 30 0.0048
259 RALES 28 0.0048
260 BLADDER SPASM 9 0.0048
261 ISCHAEMIA 22 0.0048
262 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
263 HEPATITIS FULMINANT 14 0.0047
264 EMBOLISM VENOUS 14 0.0046
265 THROMBOPHLEBITIS 16 0.0046
266 SEPSIS 505 0.0045
267 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 12 0.0045
268 TRANSPLANT FAILURE 11 0.0045
269 CEREBRAL ISCHAEMIA 23 0.0045
270 ORGAN FAILURE 18 0.0045
271 LOWER GASTROINTESTINAL HAEMORRHAGE 33 0.0045
272 GASTROINTESTINAL NECROSIS 13 0.0045
273 EMBOLISM 37 0.0045
274 EAR HAEMORRHAGE 9 0.0044
275 RENAL FAILURE CHRONIC 34 0.0044
276 HYPERNATRAEMIA 22 0.0044
277 OSTEOLYSIS 9 0.0044
278 CAROTID ARTERY OCCLUSION 16 0.0044
279 SUBDURAL HAEMORRHAGE 12 0.0044
280 UNRESPONSIVE TO STIMULI 113 0.0044
281 RASH MACULO-PAPULAR 97 0.0044
282 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38 0.0043
283 BLOOD ALBUMIN DECREASED 34 0.0043
284 THROMBOCYTOPENIA 479 0.0043
285 OTITIS MEDIA 14 0.0042
286 DUODENITIS 13 0.0042
287 PREMATURE DELIVERY 67 0.0042
288 SUSPECTED OFF LABEL USE 19 0.0042
289 ISCHAEMIC STROKE 75 0.0042
290 HYPERKALAEMIA 147 0.0042
291 BLOOD PRESSURE SYSTOLIC DECREASED 19 0.0042
292 ENTEROCOCCAL INFECTION 20 0.0041
293 MICTURITION URGENCY 47 0.0041
294 VENTRICULAR ARRHYTHMIA 15 0.0041
295 MOUTH HAEMORRHAGE 30 0.0041
296 HYPERCHOLESTEROLAEMIA 39 0.0040
297 PORTAL VEIN THROMBOSIS 13 0.0040
298 DIVERTICULUM INTESTINAL HAEMORRHAGIC 9 0.0040
299 CEREBROVASCULAR DISORDER 12 0.0040
300 FULL BLOOD COUNT ABNORMAL 42 0.0040
301 KLEBSIELLA INFECTION 20 0.0040
302 TOXIC ENCEPHALOPATHY 20 0.0039
303 FIBRIN D DIMER INCREASED 14 0.0039
304 HAEMORRHAGIC DIATHESIS 14 0.0039
305 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
306 CHEST X-RAY ABNORMAL 12 0.0039
307 MEAN CELL VOLUME INCREASED 10 0.0039
308 LEUKOCYTOSIS 70 0.0039
309 ACUTE MYOCARDIAL INFARCTION 114 0.0039
310 TALIPES 12 0.0039
311 STAPHYLOCOCCAL SEPSIS 19 0.0038
312 DUODENAL ULCER 27 0.0038
313 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
314 RESPIRATORY ACIDOSIS 15 0.0038
315 CORONARY ARTERY STENOSIS 19 0.0038
316 KIDNEY TRANSPLANT REJECTION 18 0.0037
317 FEBRILE NEUTROPENIA 248 0.0037
318 DIABETES INSIPIDUS 9 0.0037
319 RECURRENT CANCER 15 0.0037
320 OEDEMA MOUTH 12 0.0037
321 PREMATURE BABY 109 0.0036
322 HIGH DENSITY LIPOPROTEIN DECREASED 12 0.0036
323 ANGIOPATHY 20 0.0036
324 HAEMOGLOBIN DECREASED 365 0.0036
325 BLOOD PRESSURE DECREASED 236 0.0035
326 CANCER PAIN 9 0.0035
327 ECCHYMOSIS 24 0.0035
328 PSEUDOMONAS INFECTION 30 0.0035
329 HYDROCEPHALUS 19 0.0035
330 STEVENS-JOHNSON SYNDROME 77 0.0035
331 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 89 0.0035
332 SEPTIC SHOCK 149 0.0034
333 ATELECTASIS 33 0.0034
334 ESCHERICHIA INFECTION 28 0.0034
335 PURPURA 30 0.0034
336 HAEMORRHAGE 351 0.0034
337 TUMOUR MARKER INCREASED 16 0.0033
338 CENTRAL VENOUS CATHETERISATION 10 0.0033
339 POOR PERIPHERAL CIRCULATION 14 0.0033
340 PATENT DUCTUS ARTERIOSUS 13 0.0033
341 HYPOVOLAEMIA 19 0.0032
342 BRAIN NATRIURETIC PEPTIDE INCREASED 10 0.0032
343 HAEMOPTYSIS 90 0.0032
344 MELAENA 71 0.0032
345 MONOPLEGIA 14 0.0032
346 ENDOTRACHEAL INTUBATION 9 0.0032
347 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
348 WOUND COMPLICATION 11 0.0032
349 HAEMORRHAGIC STROKE 25 0.0032
350 RESPIRATORY RATE DECREASED 10 0.0032
351 HAEMATURIA 109 0.0032
352 HYPOXIA 112 0.0032
353 DERMATITIS BULLOUS 23 0.0032
354 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
355 PETECHIAE 33 0.0032
356 FAECES SOFT 23 0.0032
357 PNEUMONIA BACTERIAL 29 0.0032
358 CAROTID ARTERY STENOSIS 11 0.0031
359 BLOOD MAGNESIUM DECREASED 27 0.0031
360 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 163 0.0031
361 DEVICE RELATED INFECTION 48 0.0031
362 VULVOVAGINAL PAIN 15 0.0031
363 TRANSAMINASES INCREASED 69 0.0031
364 SHOCK 71 0.0031
365 CHOLESTASIS 59 0.0031
366 HYPERVOLAEMIA 15 0.0030
367 GENERAL PHYSICAL HEALTH DETERIORATION 351 0.0030
368 IRON DEFICIENCY ANAEMIA 28 0.0030
369 ACUTE PULMONARY OEDEMA 17 0.0030
370 CYTOLYTIC HEPATITIS 10 0.0030
371 METABOLIC ENCEPHALOPATHY 9 0.0030
372 ACUTE RESPIRATORY DISTRESS SYNDROME 53 0.0030
373 ARTERIOSPASM CORONARY 12 0.0030
374 BLOOD CHOLESTEROL INCREASED 139 0.0030
375 CARDIAC ARREST 245 0.0030
376 BLOOD CREATININE INCREASED 193 0.0030
377 BLOOD CREATINE INCREASED 13 0.0029
378 PROTEIN TOTAL DECREASED 11 0.0029
379 PORTAL HYPERTENSION 9 0.0029
380 ILEUS PARALYTIC 13 0.0029
381 PLATELET COUNT DECREASED 310 0.0029
382 CATHETER SITE INFECTION 11 0.0029
383 AORTIC DISSECTION 12 0.0029
384 FOETAL DEATH 15 0.0029
385 BLOOD BLISTER 9 0.0029
386 HYPOTENSION 577 0.0029
387 NECROSIS 16 0.0029
388 POST PROCEDURAL COMPLICATION 55 0.0029
389 MYOCLONUS 34 0.0028
390 ABDOMINAL DISTENSION 297 0.0028
391 PLEURAL EFFUSION 173 0.0028
392 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
393 CARDIOPULMONARY FAILURE 11 0.0028
394 ENCEPHALOPATHY 69 0.0028
395 ADRENAL INSUFFICIENCY 34 0.0028
396 BRAIN OEDEMA 35 0.0028
397 THROMBOTIC MICROANGIOPATHY 27 0.0028
398 LIVER FUNCTION TEST INCREASED 59 0.0027
399 CORONARY ARTERY DISEASE 83 0.0027
400 ENDOCARDITIS 14 0.0027
401 HAEMOLYSIS 21 0.0027
402 PEPTIC ULCER 9 0.0027
403 RIGHT VENTRICULAR FAILURE 19 0.0027
404 HEPATIC FUNCTION ABNORMAL 101 0.0027
405 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
406 STILLBIRTH 13 0.0027
407 BRONCHIECTASIS 18 0.0027
408 VENTRICULAR TACHYCARDIA 44 0.0027
409 BRONCHOPNEUMONIA 9 0.0026
410 HAEMODIALYSIS 22 0.0026
411 CYTOPENIA 32 0.0026
412 CARDIAC FAILURE CHRONIC 11 0.0026
413 ANAEMIA 492 0.0026
414 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
415 CARDIAC FAILURE ACUTE 17 0.0025
416 PERICARDIAL EFFUSION 59 0.0025
417 ASPARTATE AMINOTRANSFERASE INCREASED 134 0.0025
418 INTRACRANIAL PRESSURE INCREASED 14 0.0025
419 OESOPHAGEAL CANDIDIASIS 10 0.0025
420 OBSTRUCTION 10 0.0025
421 CHRONIC GRAFT VERSUS HOST DISEASE 9 0.0025
422 RENAL INJURY 74 0.0025
423 INTERNATIONAL NORMALISED RATIO DECREASED 10 0.0025
424 RESPIRATORY FAILURE 180 0.0025
425 PULMONARY HYPERTENSION 51 0.0024
426 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
427 TACHYPNOEA 33 0.0024
428 HAEMOGLOBIN INCREASED 11 0.0024
429 CIRCULATORY COLLAPSE 41 0.0024
430 RENAL FAILURE ACUTE 102 0.0024
431 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
432 DERMATITIS EXFOLIATIVE 12 0.0024
433 HYPERTRIGLYCERIDAEMIA 14 0.0024
434 LIVE BIRTH 20 0.0024
435 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
436 TUMOUR LYSIS SYNDROME 21 0.0024
437 HAEMATOCRIT DECREASED 47 0.0024
438 CARDIO-RESPIRATORY ARREST 99 0.0024
439 ANAPHYLACTIC SHOCK 61 0.0024
440 HEMIPARESIS 40 0.0024
441 GASTRIC ULCER HAEMORRHAGE 13 0.0023
442 STREPTOCOCCAL INFECTION 13 0.0023
443 CORONARY ARTERY OCCLUSION 32 0.0023
444 DECUBITUS ULCER 19 0.0023
445 HAEMATEMESIS 59 0.0023
446 GASTRIC ULCER 44 0.0023
447 HYPERAESTHESIA 19 0.0023
448 PREMATURE LABOUR 13 0.0023
449 THERAPEUTIC RESPONSE DECREASED 139 0.0023
450 URINE OUTPUT DECREASED 20 0.0023
451 DIVERTICULUM INTESTINAL 10 0.0023
452 DIABETES MELLITUS 172 0.0023
453 MUCOSAL INFLAMMATION 59 0.0023
454 AZOTAEMIA 9 0.0023
455 INFUSION SITE EXTRAVASATION 14 0.0022
456 OBSTRUCTIVE AIRWAYS DISORDER 25 0.0022
457 RESPIRATORY DISTRESS 62 0.0022
458 CYSTITIS HAEMORRHAGIC 9 0.0022
459 DRY MOUTH 181 0.0022
460 SEASONAL ALLERGY 31 0.0022
461 RENAL FAILURE 290 0.0022
462 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
463 HEMIPLEGIA 18 0.0022
464 SWELLING 202 0.0022
465 HEART RATE ABNORMAL 12 0.0021
466 DRUG EXPOSURE DURING PREGNANCY 73 0.0021
467 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
468 GINGIVAL PAIN 17 0.0021
469 HYPERBILIRUBINAEMIA 22 0.0021
470 HEPATIC FAILURE 64 0.0021
471 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
472 WHITE BLOOD CELL COUNT INCREASED 81 0.0021
473 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
474 HYPOKALAEMIA 97 0.0021
475 ACIDOSIS 16 0.0021
476 ABDOMINAL PAIN 487 0.0021
477 ANURIA 18 0.0021
478 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
479 PNEUMOTHORAX 33 0.0021
480 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
481 SLEEP DISORDER 146 0.0021
482 HAEMORRHAGIC ANAEMIA 9 0.0020
483 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
484 RENAL TUBULAR NECROSIS 20 0.0020
485 CARDIOMYOPATHY 30 0.0020
486 ACUTE RESPIRATORY FAILURE 39 0.0020
487 BLOOD IRON DECREASED 24 0.0020
488 GASTROINTESTINAL HAEMORRHAGE 169 0.0020
489 JOINT INJURY 43 0.0020
490 ILEUS 25 0.0020
491 HYPOCALCAEMIA 38 0.0020
492 FEAR 54 0.0020
493 PHARMACEUTICAL PRODUCT COMPLAINT 52 0.0020
494 TOXIC SKIN ERUPTION 20 0.0020
495 PERITONITIS 41 0.0020
496 CYANOSIS 31 0.0020
497 MALNUTRITION 22 0.0020
498 TRANSIENT ISCHAEMIC ATTACK 66 0.0020
499 C-REACTIVE PROTEIN INCREASED 71 0.0019
500 SPINAL OSTEOARTHRITIS 17 0.0019
501 MYOCARDIAL ISCHAEMIA 22 0.0019
502 ERYTHEMA MULTIFORME 18 0.0019
503 ARTERIAL OCCLUSIVE DISEASE 15 0.0019
504 PRODUCT LABEL CONFUSION 11 0.0019
505 LARGE INTESTINE POLYP 13 0.0019
506 LIVER DISORDER 83 0.0019
507 DRY THROAT 19 0.0019
508 ANHEDONIA 49 0.0019
509 EPISTAXIS 139 0.0019
510 ANGINA UNSTABLE 12 0.0018
511 CANDIDA INFECTION 31 0.0018
512 CONSTIPATION 399 0.0018
513 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
514 ACUTE KIDNEY INJURY 278 0.0018
515 ACUTE CORONARY SYNDROME 15 0.0018
516 ANAPHYLACTIC REACTION 100 0.0018
517 FOETAL GROWTH RESTRICTION 11 0.0018
518 MATERNAL EXPOSURE DURING PREGNANCY 160 0.0018
519 SPUTUM DISCOLOURED 17 0.0018
520 PANCYTOPENIA 100 0.0018
521 TORSADE DE POINTES 14 0.0018
522 DEVICE OCCLUSION 25 0.0018
523 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
524 MITRAL VALVE INCOMPETENCE 20 0.0018
525 PHARYNGEAL OEDEMA 27 0.0018
526 METABOLIC ACIDOSIS 56 0.0017
527 PULMONARY CONGESTION 23 0.0017
528 POOR VENOUS ACCESS 18 0.0017
529 EXERCISE TOLERANCE DECREASED 10 0.0017
530 VENTRICULAR EXTRASYSTOLES 18 0.0017
531 PARAESTHESIA ORAL 25 0.0017
532 HYPERTRANSAMINASAEMIA 12 0.0017
533 HEPATITIS 44 0.0017
534 GAMMA-GLUTAMYLTRANSFERASE INCREASED 38 0.0017
535 RENAL IMPAIRMENT 144 0.0017
536 HYPERTHERMIA 13 0.0017
537 JOINT DISLOCATION 18 0.0017
538 ARTERIOSCLEROSIS 16 0.0017
539 CARDIAC FAILURE 135 0.0017
540 PNEUMONIA ASPIRATION 42 0.0017
541 PULMONARY MASS 25 0.0017
542 BRADYCARDIA 89 0.0017
543 GRAFT VERSUS HOST DISEASE 12 0.0017
544 INTENTIONAL PRODUCT MISUSE 146 0.0017
545 DERMATITIS CONTACT 19 0.0017
546 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
547 MYOCARDIAL INFARCTION 287 0.0016
548 STAPHYLOCOCCAL INFECTION 54 0.0016
549 JAUNDICE 44 0.0016
550 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0016
551 ATRIAL FLUTTER 13 0.0016
552 BLOOD BILIRUBIN INCREASED 44 0.0016
553 THIRST 29 0.0016
554 DIALYSIS 23 0.0016
555 EJECTION FRACTION DECREASED 25 0.0016
556 HYDRONEPHROSIS 12 0.0016
557 HYPOTONIA 16 0.0016
558 ATRIAL FIBRILLATION 156 0.0016
559 DRUG INTOLERANCE 154 0.0016
560 INFUSION SITE SWELLING 10 0.0016
561 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
562 CARDIOVASCULAR DISORDER 40 0.0016
563 OEDEMA PERIPHERAL 191 0.0016
564 TACHYCARDIA 139 0.0016
565 HYPERGLYCAEMIA 57 0.0016
566 FOETAL EXPOSURE DURING PREGNANCY 127 0.0016
567 AGRANULOCYTOSIS 29 0.0016
568 PULMONARY TOXICITY 11 0.0016
569 SINUS TACHYCARDIA 22 0.0015
570 APNOEA 12 0.0015
571 PARALYSIS 22 0.0015
572 OXYGEN SATURATION DECREASED 86 0.0015
573 BONE MARROW FAILURE 31 0.0015
574 COVID-19 PNEUMONIA 18 0.0015
575 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
576 ORAL CANDIDIASIS 20 0.0015
577 CHOLECYSTITIS 18 0.0015
578 GENERALISED TONIC-CLONIC SEIZURE 25 0.0015
579 RASH PUSTULAR 11 0.0015
580 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
581 TRANSPLANT REJECTION 12 0.0015
582 NEUTROPHIL COUNT DECREASED 61 0.0015
583 PULMONARY OEDEMA 67 0.0015
584 HEREDITARY ANGIOEDEMA 16 0.0015
585 WRONG PRODUCT ADMINISTERED 10 0.0015
586 CARDIOMEGALY 18 0.0015
587 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
588 GENERALISED OEDEMA 18 0.0015
589 CHOLANGITIS 9 0.0015
590 JOINT EFFUSION 10 0.0014
591 LYMPHOEDEMA 10 0.0014
592 PYREXIA 499 0.0014
593 EOSINOPHIL COUNT INCREASED 12 0.0014
594 WEIGHT FLUCTUATION 15 0.0014
595 CONDITION AGGRAVATED 431 0.0014
596 LUNG DISORDER 69 0.0014
597 INTERSTITIAL LUNG DISEASE 68 0.0014
598 DRUG-INDUCED LIVER INJURY 44 0.0014
599 RENAL CYST 11 0.0014
600 CYTOMEGALOVIRUS INFECTION 23 0.0014
601 DRUG ERUPTION 24 0.0014
602 POST PROCEDURAL INFECTION 11 0.0014
603 NERVOUS SYSTEM DISORDER 42 0.0013
604 LIVER INJURY 33 0.0013
605 ANAL INCONTINENCE 12 0.0013
606 STATUS EPILEPTICUS 15 0.0013
607 VOMITING 621 0.0013
608 INFUSION SITE PAIN 17 0.0013
609 GINGIVAL BLEEDING 18 0.0013
610 PRODUCT QUALITY ISSUE 179 0.0013
611 MEDICATION ERROR 73 0.0013
612 RETCHING 28 0.0013
613 HEART RATE DECREASED 46 0.0013
614 SMALL INTESTINAL OBSTRUCTION 16 0.0013
615 GRAND MAL CONVULSION 12 0.0013
616 LARGE INTESTINE PERFORATION 9 0.0013
617 HYPOMAGNESAEMIA 18 0.0013
618 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
619 EXTRASYSTOLES 9 0.0013
620 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
621 ANGIOEDEMA 57 0.0013
622 LUNG INFECTION 20 0.0013
623 CARPAL TUNNEL SYNDROME 18 0.0013
624 FLANK PAIN 12 0.0013
625 BODY TEMPERATURE INCREASED 26 0.0013
626 EXPOSURE DURING PREGNANCY 79 0.0013
627 MENTAL STATUS CHANGES 35 0.0013
628 CONTRAINDICATED PRODUCT ADMINISTERED 38 0.0013
629 SNEEZING 28 0.0012
630 LUNG INFILTRATION 11 0.0012
631 BLOOD CALCIUM DECREASED 14 0.0012
632 LEUKOPENIA 62 0.0012
633 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
634 LIVER FUNCTION TEST ABNORMAL 36 0.0012
635 HAEMOLYTIC ANAEMIA 11 0.0012
636 GASTROINTESTINAL INFECTION 11 0.0012
637 INTERNAL HAEMORRHAGE 14 0.0012
638 GASTRITIS 32 0.0012
639 HYPERCALCAEMIA 15 0.0012
640 ELECTROLYTE IMBALANCE 14 0.0012
641 RESTLESSNESS 44 0.0012
642 VASCULITIS 14 0.0012
643 CHEST PAIN 222 0.0012
644 RASH GENERALISED 31 0.0012
645 HYPOAESTHESIA ORAL 18 0.0012
646 UROSEPSIS 11 0.0012
647 APHASIA 36 0.0012
648 DRUG INTERACTION 189 0.0012
649 PERITONITIS BACTERIAL 12 0.0012
650 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
651 PALLOR 32 0.0012
652 RHABDOMYOLYSIS 49 0.0012
653 PRODUCT USE IN UNAPPROVED INDICATION 291 0.0012
654 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
655 CELLULITIS 59 0.0012
656 BLOOD POTASSIUM INCREASED 19 0.0012
657 FLUID OVERLOAD 17 0.0012
658 ATRIOVENTRICULAR BLOCK 9 0.0012
659 SOMNOLENCE 234 0.0012
660 PNEUMONIA 376 0.0012
661 OSTEOMYELITIS 21 0.0012
662 PANCREATITIS ACUTE 26 0.0012
663 HYPOGLYCAEMIA 56 0.0012
664 DRUG LEVEL INCREASED 19 0.0011
665 PULMONARY FIBROSIS 22 0.0011
666 CARDIAC FAILURE CONGESTIVE 92 0.0011
667 INCONTINENCE 12 0.0011
668 DRUG EFFECT DECREASED 61 0.0011
669 DYSMENORRHOEA 15 0.0011
670 GASTRIC HAEMORRHAGE 13 0.0011
671 HEPATIC STEATOSIS 21 0.0011
672 INJURY 79 0.0011
673 RED BLOOD CELL COUNT DECREASED 32 0.0011
674 COMA 53 0.0011
675 INSURANCE ISSUE 17 0.0011
676 POLYURIA 9 0.0011
677 CYTOKINE RELEASE SYNDROME 22 0.0011
678 PERIPHERAL COLDNESS 15 0.0011
679 RESPIRATORY ARREST 30 0.0011
680 MUSCULOSKELETAL STIFFNESS 94 0.0011
681 HEPATOCELLULAR INJURY 15 0.0011
682 MENTAL DISORDER 46 0.0011
683 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
684 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
685 PYELONEPHRITIS 9 0.0010
686 DYSPNOEA EXERTIONAL 39 0.0010
687 WHITE BLOOD CELL COUNT DECREASED 112 0.0010
688 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
689 HAEMORRHOIDS 20 0.0010
690 HYPERTENSION 217 0.0010
691 OEDEMA 55 0.0010
692 LIGAMENT SPRAIN 10 0.0010
693 PULMONARY THROMBOSIS 11 0.0010
694 DELIRIUM 35 0.0010
695 OESOPHAGITIS 11 0.0010
696 HEART RATE INCREASED 99 0.0010
697 DISEASE RECURRENCE 47 0.0010
698 DYSPNOEA 559 0.0010
699 MOTOR DYSFUNCTION 10 0.0010
700 CEREBROVASCULAR ACCIDENT 165 0.0010
701 MYELOSUPPRESSION 35 0.0010
702 HYPOKINESIA 14 0.0010
703 FLUSHING 98 0.0010
704 RASH ERYTHEMATOUS 46 0.0010
705 MYOCARDITIS 11 0.0010
706 SKIN DISCOLOURATION 44 0.0010
707 NAUSEA 757 0.0010
708 CHILLS 111 0.0009
709 PROTEINURIA 18 0.0009
710 SUDDEN DEATH 10 0.0009
711 CAESAREAN SECTION 11 0.0009
712 SKIN ULCER 24 0.0009
713 BLISTER 52 0.0009
714 PRODUCT PREPARATION ERROR 19 0.0009
715 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
716 CONJUNCTIVITIS 17 0.0009
717 BRONCHOSPASM 13 0.0009
718 INFECTION 131 0.0009
719 PRESYNCOPE 22 0.0009
720 PROCEDURAL PAIN 25 0.0009
721 OFF LABEL USE 788 0.0009
722 UNEVALUABLE EVENT 68 0.0009
723 BURNING SENSATION 63 0.0009
724 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
725 INJECTION SITE HAEMATOMA 13 0.0009
726 CHRONIC KIDNEY DISEASE 68 0.0009
727 SLEEP APNOEA SYNDROME 17 0.0009
728 CHEST DISCOMFORT 91 0.0009
729 DERMATITIS ALLERGIC 11 0.0009
730 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
731 PRODUCTIVE COUGH 41 0.0009
732 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
733 HYPERHIDROSIS 110 0.0009
734 SPLENOMEGALY 10 0.0009
735 SPINAL PAIN 10 0.0009
736 LETHARGY 49 0.0009
737 THERAPY NON-RESPONDER 38 0.0008
738 BLOOD URINE PRESENT 16 0.0008
739 LOSS OF CONSCIOUSNESS 107 0.0008
740 FACE OEDEMA 14 0.0008
741 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 28 0.0008
742 URINARY TRACT INFECTION 141 0.0008
743 SKIN FISSURES 16 0.0008
744 FEELING HOT 50 0.0008
745 RECTAL HAEMORRHAGE 35 0.0008
746 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
747 VAGINAL HAEMORRHAGE 35 0.0008
748 RESPIRATORY TRACT INFECTION 21 0.0008
749 ARRHYTHMIA 38 0.0008
750 RESPIRATORY DISORDER 24 0.0008
751 DRUG INEFFECTIVE 1054 0.0008
752 HEPATIC CIRRHOSIS 15 0.0008
753 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
754 ADVERSE EVENT 72 0.0008
755 ABDOMINAL PAIN UPPER 160 0.0008
756 ANOREXIA 10 0.0008
757 PRESCRIBED OVERDOSE 15 0.0008
758 NEUTROPENIA 105 0.0008
759 LACTIC ACIDOSIS 25 0.0008
760 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
761 HEPATIC ENZYME INCREASED 52 0.0008
762 WHEEZING 45 0.0008
763 GASTROENTERITIS 11 0.0008
764 POLYNEUROPATHY 9 0.0008
765 BLOOD PRESSURE FLUCTUATION 18 0.0007
766 SENSORY DISTURBANCE 12 0.0007
767 NEOPLASM PROGRESSION 26 0.0007
768 ASTHENIA 280 0.0007
769 ACCIDENTAL OVERDOSE 27 0.0007
770 RESPIRATORY DEPRESSION 9 0.0007
771 ANGINA PECTORIS 21 0.0007
772 MUSCLE SPASTICITY 9 0.0007
773 ACUTE HEPATIC FAILURE 10 0.0007
774 HAEMATOCHEZIA 40 0.0007
775 DRUG DISPENSING ERROR 11 0.0007
776 EPILEPSY 22 0.0007
777 SECRETION DISCHARGE 9 0.0007
778 FEELING COLD 20 0.0007
779 HIP ARTHROPLASTY 11 0.0007
780 INTESTINAL OBSTRUCTION 27 0.0007
781 KIDNEY INFECTION 14 0.0007
782 MUSCULAR WEAKNESS 80 0.0007
783 CONVULSION 40 0.0007
784 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
785 EMOTIONAL DISTRESS 84 0.0007
786 SKIN LESION 19 0.0007
787 ABSCESS 11 0.0007
788 ABASIA 17 0.0007
789 FOOT FRACTURE 13 0.0007
790 GASTROINTESTINAL DISORDER 60 0.0007
791 SYNCOPE 67 0.0007
792 DEHYDRATION 89 0.0007
793 SINUS CONGESTION 9 0.0007
794 PALPITATIONS 78 0.0007
795 DRUG RESISTANCE 17 0.0007
796 CYSTITIS 21 0.0007
797 FIBROMYALGIA 16 0.0007
798 DYSURIA 24 0.0007
799 TREATMENT FAILURE 54 0.0007
800 PRESCRIBED UNDERDOSE 13 0.0007
801 TREMOR 108 0.0007
802 INFUSION RELATED REACTION 42 0.0006
803 BLOOD POTASSIUM DECREASED 19 0.0006
804 LIP SWELLING 21 0.0006
805 HYPOPHAGIA 16 0.0006
806 PNEUMONITIS 17 0.0006
807 COLD SWEAT 11 0.0006
808 HYPERTHYROIDISM 9 0.0006
809 CHROMATURIA 14 0.0006
810 CONFUSIONAL STATE 100 0.0006
811 ECZEMA 32 0.0006
812 IMMUNODEFICIENCY 9 0.0006
813 BLOOD PRESSURE ABNORMAL 12 0.0006
814 ASTHMA 68 0.0006
815 SKIN DISORDER 20 0.0006
816 URINARY RETENTION 20 0.0006
817 DEVICE FAILURE 9 0.0006
818 PLASMA CELL MYELOMA 23 0.0006
819 DIARRHOEA 380 0.0006
820 HYPOAESTHESIA 88 0.0006
821 PARAESTHESIA 92 0.0006
822 HEPATOTOXICITY 13 0.0006
823 DYSPHAGIA 55 0.0006
824 ERYTHEMA 119 0.0006
825 HEART RATE IRREGULAR 13 0.0006
826 URINARY INCONTINENCE 17 0.0006
827 SEIZURE 66 0.0006
828 CONTUSION 55 0.0006
829 HEADACHE 356 0.0006
830 DYSKINESIA 23 0.0006
831 OBESITY 9 0.0006
832 LACRIMATION INCREASED 17 0.0006
833 RENAL DISORDER 26 0.0006
834 DYSARTHRIA 21 0.0006
835 HYPERSENSITIVITY 103 0.0006
836 FAECES DISCOLOURED 12 0.0006
837 PANCREATITIS 29 0.0005
838 URTICARIA 91 0.0005
839 DECREASED APPETITE 126 0.0005
840 DIPLOPIA 14 0.0005
841 COUGH 151 0.0005
842 FLUID RETENTION 27 0.0005
843 OROPHARYNGEAL PAIN 49 0.0005
844 STOMATITIS 32 0.0005
845 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 95 0.0005
846 EAR INFECTION 14 0.0005
847 SWELLING FACE 34 0.0005
848 CHOLELITHIASIS 17 0.0005
849 BLOOD PRESSURE INCREASED 79 0.0005
850 PAIN 317 0.0005
851 NEUROPATHY PERIPHERAL 49 0.0005
852 PRURITUS GENERALISED 11 0.0005
853 DISORIENTATION 20 0.0005
854 WOUND 14 0.0005
855 DISEASE PROGRESSION 59 0.0005
856 MUSCULOSKELETAL PAIN 26 0.0005
857 RESTLESS LEGS SYNDROME 9 0.0005
858 OVERDOSE 106 0.0005
859 THROAT TIGHTNESS 13 0.0005
860 SWOLLEN TONGUE 15 0.0005
861 FUNGAL INFECTION 16 0.0005
862 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
863 BLOOD SODIUM DECREASED 9 0.0005
864 DIZZINESS 238 0.0005
865 COVID-19 83 0.0005
866 EATING DISORDER 10 0.0005
867 RASH 202 0.0005
868 AGITATION 34 0.0005
869 MALAISE 203 0.0005
870 SPEECH DISORDER 24 0.0005
871 JOINT STIFFNESS 12 0.0005
872 INJECTION SITE RASH 14 0.0005
873 BACK PAIN 106 0.0005
874 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
875 ANXIETY 129 0.0005
876 PRURITUS 174 0.0005
877 BLOOD GLUCOSE INCREASED 85 0.0005
878 OSTEOARTHRITIS 19 0.0004
879 FULL BLOOD COUNT DECREASED 9 0.0004
880 BRONCHITIS 33 0.0004
881 PRODUCT ADMINISTRATION ERROR 9 0.0004
882 RASH PRURITIC 24 0.0004
883 BLINDNESS 18 0.0004
884 MYALGIA 75 0.0004
885 HYPOTHYROIDISM 14 0.0004
886 DEATH 377 0.0004
887 MOVEMENT DISORDER 14 0.0004
888 NASOPHARYNGITIS 80 0.0004
889 DERMATITIS 9 0.0004
890 HALLUCINATION, VISUAL 9 0.0004
891 PAIN IN JAW 12 0.0004
892 DIABETIC KETOACIDOSIS 10 0.0004
893 NEPHROLITHIASIS 19 0.0004
894 BONE PAIN 24 0.0004
895 INFLAMMATION 21 0.0004
896 PAIN IN EXTREMITY 119 0.0004
897 ORAL PAIN 9 0.0004
898 RASH MACULAR 14 0.0004
899 IMPAIRED HEALING 13 0.0004
900 INFLUENZA LIKE ILLNESS 32 0.0004
901 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
902 POLLAKIURIA 16 0.0004
903 PERIPHERAL SWELLING 59 0.0004
904 INSOMNIA 102 0.0004
905 HERPES ZOSTER 22 0.0004
906 VERTIGO 23 0.0004
907 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
908 WEIGHT DECREASED 105 0.0004
909 LABORATORY TEST ABNORMAL 11 0.0004
910 FALL 124 0.0004
911 PRODUCT USE ISSUE 70 0.0004
912 MUSCLE SPASMS 67 0.0004
913 VISION BLURRED 50 0.0004
914 CARDIAC DISORDER 34 0.0004
915 DIVERTICULITIS 10 0.0004
916 DISCOMFORT 22 0.0004
917 FATIGUE 271 0.0003
918 PRODUCT SUBSTITUTION ISSUE 20 0.0003
919 DEAFNESS 9 0.0003
920 SEDATION 9 0.0003
921 UNDERDOSE 25 0.0003
922 NIGHT SWEATS 11 0.0003
923 OSTEOPOROSIS 14 0.0003
924 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
925 OCULAR HYPERAEMIA 16 0.0003
926 PRODUCT DOSE OMISSION ISSUE 99 0.0003
927 LIMB INJURY 9 0.0003
928 WEIGHT INCREASED 74 0.0003
929 NEOPLASM MALIGNANT 22 0.0003
930 ABORTION SPONTANEOUS 13 0.0003
931 GAIT DISTURBANCE 62 0.0003
932 DYSPEPSIA 31 0.0003
933 HYPERSOMNIA 9 0.0003
934 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
935 LYMPHADENOPATHY 11 0.0003
936 DYSSTASIA 9 0.0003
937 NECK PAIN 17 0.0003
938 EYE DISORDER 10 0.0003
939 BALANCE DISORDER 26 0.0003
940 VIRAL INFECTION 10 0.0003
941 INJECTION SITE HAEMORRHAGE 24 0.0003
942 TYPE 2 DIABETES MELLITUS 10 0.0003
943 DISTURBANCE IN ATTENTION 16 0.0003
944 HALLUCINATION 22 0.0003
945 BLOOD GLUCOSE DECREASED 14 0.0003
946 DYSPHONIA 17 0.0003
947 DRY SKIN 38 0.0003
948 SKIN EXFOLIATION 24 0.0003
949 HEAD INJURY 9 0.0003
950 RHINORRHOEA 18 0.0003
951 MIGRAINE 26 0.0003
952 COLITIS 10 0.0003
953 ILLNESS 27 0.0003
954 DEPRESSION 59 0.0003
955 INCORRECT DOSE ADMINISTERED 59 0.0003
956 INFLUENZA 28 0.0003
957 DRUG EFFECT INCOMPLETE 9 0.0002
958 EXTRA DOSE ADMINISTERED 10 0.0002
959 ABDOMINAL DISCOMFORT 41 0.0002
960 INJECTION SITE ERYTHEMA 30 0.0002
961 ROAD TRAFFIC ACCIDENT 10 0.0002
962 NASAL CONGESTION 14 0.0002
963 INJECTION SITE PRURITUS 15 0.0002
964 FEELING ABNORMAL 53 0.0002
965 ARTHRALGIA 89 0.0002
966 INJECTION SITE BRUISING 17 0.0002
967 EYE PAIN 12 0.0002
968 MOBILITY DECREASED 15 0.0002
969 HOSPITALISATION 31 0.0002
970 ADVERSE DRUG REACTION 18 0.0002
971 COGNITIVE DISORDER 9 0.0002
972 NERVOUSNESS 10 0.0002
973 DEPRESSED MOOD 10 0.0002
974 INJECTION SITE REACTION 13 0.0002
975 CATARACT 11 0.0002
976 AGGRESSION 9 0.0002
977 TOXICITY TO VARIOUS AGENTS 30 0.0002
978 AMNESIA 11 0.0002
979 THERAPY INTERRUPTED 12 0.0002
980 SINUSITIS 17 0.0002
981 JOINT SWELLING 20 0.0002
982 FLATULENCE 9 0.0002
983 ALOPECIA 31 0.0002
984 DEVICE MALFUNCTION 11 0.0002
985 DEVICE ISSUE 14 0.0002
986 ARTHRITIS 12 0.0002
987 DYSGEUSIA 11 0.0001
988 NO ADVERSE EVENT 25 0.0001
989 SKIN BURNING SENSATION 9 0.0001
990 VISUAL IMPAIRMENT 15 0.0001
991 HOT FLUSH 9 0.0001
992 INJECTION SITE PAIN 32 0.0001
993 MEMORY IMPAIRMENT 14 0.0001
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001